Found: 55
Select item for more details and to access through your institution.
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161869
- By:
- Publication type:
- Article
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aaq1238
- By:
- Publication type:
- Article
The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2507, doi. 10.3390/cancers16142507
- By:
- Publication type:
- Article
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 935, doi. 10.3390/cancers16050935
- By:
- Publication type:
- Article
Automated Cellular-Level Dual Global Fusion of Whole-Slide Imaging for Lung Adenocarcinoma Prognosis.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4824, doi. 10.3390/cancers15194824
- By:
- Publication type:
- Article
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143473
- By:
- Publication type:
- Article
Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1864, doi. 10.3390/cancers14081864
- By:
- Publication type:
- Article
Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1250, doi. 10.3390/cancers13061250
- By:
- Publication type:
- Article
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 714, doi. 10.3390/cancers11050714
- By:
- Publication type:
- Article
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 462, doi. 10.3390/cancers11040462
- By:
- Publication type:
- Article
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. e1065, doi. 10.1093/oncolo/oyad118
- By:
- Publication type:
- Article
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1457, doi. 10.1634/theoncologist.2020-0610
- By:
- Publication type:
- Article
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8<sup>+</sup> T cell exhaustion.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18298-8
- By:
- Publication type:
- Article
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12832-z
- By:
- Publication type:
- Article
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 293, doi. 10.1002/cncr.26225
- By:
- Publication type:
- Article
Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. e415, doi. 10.1016/j.cllc.2020.06.003
- By:
- Publication type:
- Article
Phase I/II Trial of Immunotherapy With Durvalumab and Tremelimumab With Continuous or Intermittent MEK Inhibitor Selumetinib in NSCLC: Early Trial Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 9, p. N.PAG, doi. 10.3390/cells11091484
- By:
- Publication type:
- Article
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010052
- By:
- Publication type:
- Article
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29539-3
- By:
- Publication type:
- Article
A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-41301-2
- By:
- Publication type:
- Article
Political Action for Science?
- Published in:
- BioScience, 1982, v. 32, n. 8, p. 650, doi. 10.1093/bioscience/32.8.650
- By:
- Publication type:
- Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1519, doi. 10.1007/s00262-020-02560-5
- By:
- Publication type:
- Article
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22875-w
- By:
- Publication type:
- Article
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02361-x
- By:
- Publication type:
- Article
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215589, doi. 10.1001/jamanetworkopen.2022.15589
- By:
- Publication type:
- Article
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. 1, doi. 10.1001/jamanetworkopen.2022.15589
- By:
- Publication type:
- Article
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1324057
- By:
- Publication type:
- Article
Pan-urologic cancer genomic subtypes that transcend tissue of origin.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00289-x
- By:
- Publication type:
- Article
A genetic cell context-dependent role for ZEB1 in lung cancer.
- Published in:
- Nature Communications, 2016, v. 7, n. 7, p. 12231, doi. 10.1038/ncomms12231
- By:
- Publication type:
- Article
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5241, doi. 10.1038/ncomms6241
- By:
- Publication type:
- Article
Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067054
- By:
- Publication type:
- Article
Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034343
- By:
- Publication type:
- Article
Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma.
- Published in:
- PLoS ONE, 2009, v. 4, n. 4, p. 1, doi. 10.1371/journal.pone.0005401
- By:
- Publication type:
- Article
Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas.
- Published in:
- Developmental Dynamics, 2018, v. 247, n. 3, p. 555, doi. 10.1002/dvdy.24485
- By:
- Publication type:
- Article
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes.
- Published in:
- Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.112
- By:
- Publication type:
- Article
A collagen glucosyltransferase drives lung adenocarcinoma progression in mice.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01982-w
- By:
- Publication type:
- Article
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 5, p. 968, doi. 10.1016/j.molonc.2013.06.001
- By:
- Publication type:
- Article
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus.
- Published in:
- Nature, 2004, v. 427, n. 6972, p. 320, doi. 10.1038/nature02239
- By:
- Publication type:
- Article
Development, characterization, and applications of multi-material stereolithography bioprinting.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82102-w
- By:
- Publication type:
- Article
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The fibrotic tumor stroma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11.
- Published in:
- 2017
- By:
- Publication type:
- journal article
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2696, doi. 10.1172/JCI72171
- By:
- Publication type:
- Article
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 9, p. 3170, doi. 10.1172/JCI63608
- By:
- Publication type:
- Article